Article
Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
PLoS pathogens - 1 Dec 2008
Wheeler Robert T, Kombe Diana, Agarwala Sudeep D, Fink Gerald R
Abstract excerpt
Candida albicans, a clinically important dimorphic fungal pathogen that can evade immune attack by masking its cell wall beta-glucan from immune recognition, mutes protective host responses mediated by the Dectin-1 beta-glucan receptor on innate immune cells. Although the ability of C. albicans to switch between a yeast- or hyphal-form is a key virulence determinant, the role of each morphotype in beta-glucan...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
